Anaphylaxis: Evidence-Based Long-Term Risk Reduction in the Community

Immunology and Allergy Clinics of North America

Volumn 27, Issue 2, 2007, Pages 231-248

  Simons, F Estelle R ^a  

^a CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMPHETAMINE DERIVATIVE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CETIRIZINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOCORTICOID; HYPNOTIC AGENT; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SALBUTAMOL; SEDATIVE AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ANAPHYLAXIS; ANXIETY; ASTHMA; COGNITIVE DEFECT; COMMUNITY CARE; COMORBIDITY; DIZZINESS; DRUG HALF LIFE; DRUG MECHANISM; EMERGENCY CARE; EVIDENCE BASED MEDICINE; EXERCISE; FATALITY; HEADACHE; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HEART PALPITATION; HUMAN; MEDICAL SPECIALIST; NERVOUSNESS; PALLOR; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOMOTOR DISORDER; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SEDATION; SIDE EFFECT; TACHYCARDIA; TREATMENT PLANNING; TREMOR; UNSPECIFIED SIDE EFFECT; URINE RETENTION; XEROSTOMIA;

ADRENERGIC AGONISTS; ANAPHYLAXIS; COMMUNITY HEALTH PLANNING; COMMUNITY HEALTH SERVICES; EPINEPHRINE; EVIDENCE-BASED MEDICINE; HEALTH EDUCATION; HUMANS; PATIENT EDUCATION; RISK REDUCTION BEHAVIOR;

EID: 34248168304     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2007.03.007     Document Type: Review

References (65)

1. Sampson H.A., Munoz-Furlong A., Bock S.A., et al. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 115 3 (2005) 584-591
2. Simons F.E.R. Anaphylaxis, killer allergy: long-term management in the community. J Allergy Clin Immunol 117 2 (2006) 367-377
3. Lieberman P, Camargo C Jr, Bohlke K, et al. Epidemiology of anaphylaxis: incidence and prevalence. Findings of the ACAAI Anaphylaxis Study Group. Ann Allergy Asthma Immunol 2006;97:596-602.
4. Clark S., Bock S.A., Gaeta T.J., et al. Multicenter study of emergency department visits for food allergies. J Allergy Clin Immunol 113 2 (2004) 347-352
5. Clark S., Long A.A., Gaeta T.J., et al. Multicenter study of emergency department visits for insect sting allergies. J Allergy Clin Immunol 116 3 (2005) 643-649
6. Lin R.Y., Schwartz L.B., Curry A., et al. Histamine and tryptase levels in patients with acute allergic reactions: an emergency department-based study. J Allergy Clin Immunol 106 1 (2000) 65-71
7. Kemp S.F., and Lockey R.F. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 110 3 (2002) 341-348
8. Beaudouin E., Renaudin J.M., Morisset M., et al. Food-dependent exercise-induced anaphylaxis-update and current data. Allerg Immunol (Paris) 38 2 (2006) 45-51
9. Lenchner K., and Grammer L.C. A current review of idiopathic anaphylaxis. Curr Opin Allergy Clin Immunol 3 4 (2003) 305-311
10. Joint Task Force on Practice Parameters; American Academy of Allergy Asthma and Immunology, American College of Allergy Asthma and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 115 3 (2005) S483-S523
11. Levels of evidence and grades of recommendation. Oxford (UK): Centre for Evidence-Based Medicine. Available at: http://www.cebm.net/levels_of_evidence.asp. Accessed October 5, 2006.
12. National Asthma Education and Prevention Program Expert Panel (NAEPP) Report. Long-term management of asthma in children: effectiveness of inhaled corticosteroids compared to other medications. J Allergy Clin Immunol 110 Suppl 5 Pt 2 (2002) S147-S160
13. Sampson H.A. Update on food allergy. J Allergy Clin Immunol 113 5 (2004) 805-819
14. Sampson H.A. Clinical practice. Peanut allergy. N Engl J Med 346 17 (2002) 1294-1299
15. Freeman T.M. Clinical practice. Hypersensitivity to Hymenoptera stings. N Engl J Med 351 19 (2004) 1978-1984
16. Golden D.B.K., Kagey-Sobotka A., Norman P.S., et al. Outcomes of allergy to insect stings in children, with and without venom immunotherapy. N Engl J Med 351 7 (2004) 668-674
17. Cohen B.L., Noone S., Munoz-Furlong A., et al. Development of a questionnaire to measure quality of life in families with a child with food allergy. J Allergy Clin Immunol 114 5 (2004) 1159-1163
18. Oude Elberink J.N.G., de Monchy J.G.R., Golden D.B., et al. Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy. J Allergy Clin Immunol 109 1 (2002) 162-170
19. Munoz-Furlong A. Daily coping strategies for patients and their families. Pediatrics 111 6 (2003) 1654-1661
20. Simons E., Weiss C.C., Furlong T.J., et al. Impact of ingredient labeling practices on food allergic consumers. Ann Allergy Asthma Immunol 95 5 (2005) 426-428
21. Akin C., and Metcalfe D.D. Occult bone marrow mastocytosis presenting as recurrent systemic anaphylaxis. J Allergy Clin Immunol 111 (2003) S206
22. Mullins R.J. Anaphylaxis: risk factors for recurrence. Clin Exp Allergy 33 8 (2003) 1033-1040
23. Ring J., Brockow K., and Behrendt H. History and classification of anaphylaxis. Novartis Found Symp 257 (2004) 6-16
24. Bock S.A., Munoz-Furlong A., and Sampson H.A. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 107 1 (2001) 191-193
25. Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction?. Curr Opin Allergy Clin Immunol 4 4 (2004) 285-290
26. TenBrook Jr. J.A., Wolf M.P., Hoffman S.N., et al. Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis. J Allergy Clin Immunol 113 5 (2004) 977-982
27. Muller U.R., and Haeberli G. Use of beta-blockers during immunotherapy for Hymenoptera venom allergy. J Allergy Clin Immunol 115 3 (2005) 606-610
28. Kemp S.F., and Lieberman P. Inhibitors of angiotensin II: potential hazards for patients at risk for anaphylaxis?. Ann Allergy Asthma Immunol 78 6 (1997) 527-529
29. Li X.-M., Srivastava K., Grishin A., et al. Persistent protective effect of heat-killed Escherichia coli producing "engineered," recombinant peanut proteins in a murine model of peanut allergy. J Allergy Clin Immunol 112 1 (2003) 159-167
30. Kraft S., Fleming T., Billingsley J.M., et al. Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo. J Exp Med 201 3 (2005) 385-396
31. Leung D.Y.M., Sampson H.A., Yunginger J.W., et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 348 11 (2003) 986-993
32. Vander Leek T.K., Liu A.H., Stefanski K., et al. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Pediatr 137 6 (2000) 749-755
33. Sicherer S.H., Furlong T.J., Munoz-Furlong A., et al. A voluntary registry for peanut and tree nut allergy: characteristics of the first 5149 registrants. J Allergy Clin Immunol 108 1 (2001) 128-132
34. Sicherer S.H., and Simons F.E.R. Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community. J Allergy Clin Immunol 115 3 (2005) 575-583
35. Simons F.E.R. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol 113 5 (2004) 837-844
36. McLean-Tooke A.P.C., Bethune C.A., Fay A.C., et al. Adrenaline in the treatment of anaphylaxis: what is the evidence?. Br Med J 327 7427 (2003) 1332-1335
37. 1-antihistamines. N Engl J Med 351 21 (2004) 2203-2217
38. 1-antihistamines for anaphylaxis: systematic review. Cochrane Database Syst Rev 2007;1:CD006160.
39. Simons F.E.R., Roberts J.R., Gu X., et al. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol 101 1 (1998) 33-37
40. Simons F.E.R., Gu X., and Simons K.J. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol 108 5 (2001) 871-873
41. Korenblat P., Lundie M.J., Dankner R.E., et al. A retrospective study of epinephrine administration for anaphylaxis: how many doses are needed?. Allergy Asthma Proc 20 6 (1999) 383-386
42. Simons F.E.R., Peterson S., and Black C.D. Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol 110 5 (2002) 647-651
43. Simons F.E.R., Peterson S., and Black C.D. Epinephrine dispensing for the out-of-hospital treatment of anaphylaxis in infants and children: a population-based study. Ann Allergy Asthma Immunol 86 6 (2001) 622-626
44. Song T.T., Nelson M.R., Chang J.H., et al. Adequacy of the epinephrine autoinjector needle length in delivering epinephrine to the intramuscular tissues. Ann Allergy Asthma Immunol 94 5 (2005) 539-542
45. Kelso J.M. A second dose of epinephrine for anaphylaxis: how often needed and how to carry. J Allergy Clin Immunol 117 2 (2006) 464-465
46. Simons F.E.R. Lack of worldwide availability of epinephrine autoinjectors for outpatients at risk of anaphylaxis. Ann Allergy Asthma Immunol 94 5 (2005) 534-538
47. Simons F.E.R., Chan E.S., Gu X., et al. Epinephrine for the out-of-hospital (first aid) treatment of anaphylaxis in infants: is the ampule/syringe/needle method practical?. J Allergy Clin Immunol 108 6 (2001) 1040-1044
48. Simons F.E.R., Gu X., Johnston L., et al. Can epinephrine inhalations be substituted for epinephrine injection in children at risk for systemic anaphylaxis?. Pediatrics 106 5 (2000) 1040-1044
49. Rawas-Qalaji M.M., Simons F.E.R., and Simons K.J. Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose-equivalence for potential treatment of anaphylaxis. J Allergy Clin Immunol 117 2 (2006) 398-403
50. Simons F.E.R., Gu X., and Simons K.J. Outdated EpiPen and EpiPen Jr auto-injectors: past their prime?. J Allergy Clin Immunol 105 5 (2000) 1025-1030
51. Marone G., Bova M., Detoraki A., et al. The human heart as a shock organ in anaphylaxis. Novartis Found Symp 257 (2004) 133-149
52. Ewan P.W., and Clark A.T. Efficacy of a management plan based on severity assessment in longitudinal and case-controlled studies of 747 children with nut allergy: proposal for good practice. Clin Exp Allergy 35 6 (2005) 751-756
53. American Academy of Allergy Asthma and Immunology Board of Directors. Anaphylaxis in schools and other child-care settings. J Allergy Clin Immunol 102 2 (1998) 173-176
54. Pumphrey R.S.H. Fatal posture in anaphylactic shock. J Allergy Clin Immunol 112 2 (2003) 451-452
55. Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol 95 (2005) 217-226
56. Gillespie C.A., Ernst F., Goritz S.S., et al. Anticipatory anaphylaxis management in a children's hospital allergy clinic: a quality assurance audit of physician and nurse recommendations and teaching. J Allergy Clin Immunol 113 (2004) S240
57. Monga S., and Manassis K. Treating anxiety in children with life-threatening anaphylactic conditions. J Am Acad Child Adolesc Psychiatry 45 8 (2006) 1007-1010
58. Rosen J.P. Empowering patients with a history of anaphylaxis to use an epinephrine autoinjector without fear. Ann Allergy Asthma Immunol 97 3 (2006) 418
59. Barnett C.W. Need for community pharmacist-provided food-allergy education and auto-injectable epinephrine training. J Am Pharm Assoc (Wash DC) 45 4 (2005) 479-485
60. Bansal P.J., Marsh R., Patel B., et al. Recognition, evaluation, and treatment of anaphylaxis in the child care setting. Ann Allergy Asthma Immunol 94 1 (2005) 55-59
61. Munoz-Furlong A. Food allergy in schools: concerns for allergists, pediatricians, parents, and school staff. Ann Allergy Asthma Immunol 93 5 (2004) S47-S50
62. McIntyre C.L., Sheetz A.H., Carroll C.R., et al. Administration of epinephrine for life-threatening allergic reactions in school settings. Pediatrics 116 5 (2005) 1134-1140
63. Murphy K.R., Hopp R.J., Kittelson E.B., et al. Life-threatening asthma and anaphylaxis in schools: a treatment model for school-based programs. Ann Allergy Asthma Immunol 96 3 (2006) 398-405
64. Hannaway P.J., Connelly M.E., Cobbett R.M., et al. Differences in race, ethnicity, and socioeconomic status in schoolchildren dispensed injectable epinephrine in 3 Massachusetts school districts. Ann Allergy Asthma Immunol 95 2 (2005) 143-148
65. Sampson M.A., Munoz-Furlong A., and Sicherer S.H. Risk-taking and coping strategies of adolescents and young adults with food allergy. J Allergy Clin Immunol 117 6 (2006) 1440-1445